KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash from Operations (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Cash from Operations for 17 consecutive years, with 1974000000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 55.53% to 1974000000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 14156000000.0, a 6.81% decrease, with the full-year FY2025 number at 14156000000.0, down 6.81% from a year prior.
  • Cash from Operations was 1974000000.0 for Q4 2025 at Bristol Myers Squibb, down from 6311000000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 6311000000.0 in Q3 2025 to a low of 1887000000.0 in Q2 2023.
  • A 5-year average of 3623950000.0 and a median of 3749500000.0 in 2022 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: skyrocketed 132.29% in 2021, then crashed 55.53% in 2025.
  • Bristol Myers Squibb's Cash from Operations stood at 4057000000.0 in 2021, then dropped by 18.51% to 3306000000.0 in 2022, then grew by 28.61% to 4252000000.0 in 2023, then increased by 4.4% to 4439000000.0 in 2024, then plummeted by 55.53% to 1974000000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMY's Cash from Operations are 1974000000.0 (Q4 2025), 6311000000.0 (Q3 2025), and 3917000000.0 (Q2 2025).